168 results
Page 5 of 9
424B5
w8j 4udb8ujejimu5
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-5.1
7d16b2kqvba
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
8-K
EX-1.1
jnx6o9q 223rrlmxh
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
9hxdw1m
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
n0ixwbe4 xhjo062b2
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.2
v83j1t
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
tty3b
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
S-8
kgeulzgxvozi3v00
30 Aug 19
Registration of securities for employees
12:30pm
S-8
EX-5.1
j0rgtwpg4j
30 Aug 19
Registration of securities for employees
12:30pm
8-K
EX-10.1
o93p5bfkpi4iqpo
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.1
u7mhey8woybfu hk90go
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
z0b3b
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am